The monoclonal antibodies market is projected to grow at a CAGR of 5.77% to reach US$158.598 billion by 2025, from US$106.134 billion in 2019. The monoclonal antibodies market is driven by steady advancement in drug improvement and disclosure, expanding occurrences of chronic diseases, good administrative approaches.